ACHIEVE: Spironolactone versus placebo in patients undergoing maintenance dialysis: an international, parallel-group, randomised controlled trial
- Homepage
- >
- Publications
- >
- ACHIEVE: Spironolactone versus placebo in patients undergoing maintenance dialysis: an international, parallel-group, randomised controlled trial
